Protagonist Therapeutics Inc buy BiotechBee
Start price
24.06.23
/
70%
€120.00
Target price
31.12.25
€40.00
Performance (%)
-
End price
31.08.23
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protagonist Therapeutics Inc | 3.448% | 3.448% | 153.165% | 450.459% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
According to BiotechBee what are the pros and cons of Protagonist Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year